A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
IDEX BIOMETRICS operates in the Software - Application industry, Technology sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 0 | - | - | - | - | - |
| Net Income | -14M | -14M | -27M | -33M | -33M | -27M |
| EPS | $-0.03 | $-0.03 | $-0.11 | $-0.16 | $-0.18 | $-0.03 |
| Free Cash Flow | -18M | -18M | -27M | -32M | -28M | -23M |
| ROIC | -640.4% | -369.3% | -419.3% | -315.3% | -622.7% | -376.3% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.42 | 0.45 | 0.05 | 0.00 | 0.03 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -22M | -22M | -27M | -31M | -31M | -26M |
| Operating Margin | 0.0% | - | - | - | - | - |
| ROE | -306.6% | -180.1% | -155.8% | -107.9% | -129.6% | -176.4% |
| Shares Outstanding | 832M | 832M | 1,397M | 1,166M | 1,010M | 832M |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | -4.4M | -1.9M | -2.7M | -3.3M | -2.4M | -2.5M | -2.5M |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | -32M | -26M | -31M | -31M | -27M | -22M | -22M |
| Op. Margin | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Net Income | -32M | -27M | -33M | -33M | -27M | -14M | -14M |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||
| ROIC | -142.1% | N/M | N/M | N/M | N/M | N/M | N/M |
| ROE | -182.0% | -176.4% | -129.6% | -107.9% | -155.8% | -180.1% | -306.6% |
| ROA | N/A | -157.3% | -110.3% | -92.0% | -98.7% | -82.0% | -140.3% |
| Cash Flow | |||||||
| Op. Cash Flow | -27M | -23M | -28M | -31M | -27M | -18M | -18M |
| Free Cash Flow | -28M | -23M | -28M | -32M | -27M | -18M | -18M |
| Owner Earnings | -31M | -28M | -32M | -35M | -30M | -20M | -20M |
| CapEx | 850K | 152K | 141K | 267K | 243K | 0 | 0 |
| Maint. CapEx | 1.6M | 1.7M | 1.8M | 1.4M | 1.6M | 2.5M | 2.5M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | N/A | 0 |
| D&A | 1.6M | 1.7M | 1.8M | 1.4M | 1.6M | 2.5M | 2.5M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | 2.5M | 2.8M | 2.8M | 2.7M | 1.3M | 351K | 351K |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 2.7M | 2.7M |
| Balance Sheet | |||||||
| Net Debt | N/A | -7.0M | -34M | -15M | -6.3M | -28K | -2.0M |
| Cash & Equiv. | 14M | 7.3M | 34M | 16M | 11M | 2.0M | 2.0M |
| Long-Term Debt | N/A | N/A | N/A | N/A | 0 | 2.0M | 2.0M |
| Debt/Equity | N/A | 0.03 | 0.00 | 0.05 | 0.45 | 0.42 | 0.00 |
| Interest Coverage | -91.3 | -55.4 | -27.9 | -22.0 | -42.0 | -9.1 | -9.1 |
| Equity | 18M | 13M | 38M | 23M | 11M | 4.7M | 4.7M |
| Total Assets | N/A | 17M | 42M | 29M | 25M | 10M | 10M |
| Total Liabilities | N/A | 4.5M | 4.3M | 6.2M | 14M | 5.6M | 5.6M |
| Intangibles | N/A | N/A | N/A | N/A | 1.0M | 569K | 569K |
| Retained Earnings | N/A | -15M | -271M | -303M | -330M | -344M | -344M |
| Working Capital | N/A | 6.7M | 33M | 19M | 7.9M | 5.8M | 5.8M |
| Current Assets | N/A | 11M | 37M | 24M | 20M | 9.3M | 9.3M |
| Current Liabilities | N/A | 4.2M | 4.3M | 5.0M | 12M | 3.5M | 3.5M |
| Per Share Data | |||||||
| EPS | N/A | -0.03 | -0.18 | -0.16 | -0.11 | -0.03 | -0.03 |
| Owner EPS | N/A | -0.03 | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 |
| Book Value | N/A | 0.02 | 0.04 | 0.02 | 0.01 | 0.01 | 0.01 |
| Cash Flow/Share | N/A | -0.03 | -0.03 | -0.03 | -0.02 | -0.02 | -0.01 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | N/A | 832.1M | 1.0B | 1.2B | 1.4B | 831.6M | 831.6M |
| Valuation | |||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | -248.0 | -310.0 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | N/A | -0.0% | -0.0% | -0.0% | -0.0% | -0.3% | -0.2% |
| Market Cap | 0 | 548.7B | 825.6B | 318.9B | 195.6B | 6.2B | 7.7B |
| Avg. Price | 595.37 | 390.09 | 661.33 | 362.04 | 184.34 | 60.31 | 9.30 |
| Year-End Price | 323.11 | 659.40 | 817.15 | 273.40 | 140.00 | 7.44 | 9.30 |
IDEX BIOMETRICS passes 0 of 9 quality checks, indicating weak fundamentals.
IDEX BIOMETRICS (IDEX-OL) has a market capitalization of $7.7B. It is classified as a mid-cap stock.
IDEX BIOMETRICS (IDEX-OL) does not currently pay a regular dividend.
IDEX BIOMETRICS (IDEX-OL) operates in the Software - Application industry, within the Technology sector.
IDEX BIOMETRICS (IDEX-OL) generated $-18 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
IDEX BIOMETRICS (IDEX-OL) has a debt-to-equity ratio of 0.42. This indicates a conservatively financed balance sheet.
IDEX BIOMETRICS (IDEX-OL) reported earnings per share (EPS) of $-0.03 in its most recent fiscal year.
IDEX BIOMETRICS (IDEX-OL) has a return on equity (ROE) of -180.1%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 6 years of financial data for IDEX BIOMETRICS (IDEX-OL), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
IDEX BIOMETRICS (IDEX-OL) has a book value per share of $0.01, based on its most recent annual SEC filing.